A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Completed · Phase 3 · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia (BPH)

In brief

A new drug for benign prostatic hyperplasia is compared to placebo for to determine if it is safe and effective. The study lasts approximately 20 weeks.

Key facts

Study ID

NCT00224107

Run by

Watson Pharmaceuticals

People needed

461

Starts

2005-05-01

Expected to finish

2006-08-01

Last updated by the study team

2011-07-12

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males in good general health and at least 50 years of age, with symptoms of moderate to severe benign prostatic hyperplasia.

You may not qualify if…

• Medical conditions that would confound the efficacy evaluation.
• Medical conditions in which it would be unsafe to use an alpha-blocker.
• The use of concomitant drugs that would confound the efficacy evaluation.
• The use of concomitant drugs that would be unsafe with this alpha-blocker.

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Tucson, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Culver City, California, United States
• Study site — Irvine, California, United States
• Study site — La Jolla, California, United States
• Study site — Long Beach, California, United States
• Study site — Newport Beach, California, United States
• Study site — San Diego, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Wheat Ridge, Colorado, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Aventura, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Coral Gables, Florida, United States
• Study site — Pensacola, Florida, United States
• Study site — Marietta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Peoria, Illinois, United States
• Study site — Des Moines, Iowa, United States
• Study site — Saint Joseph, Michigan, United States
• Study site — Edina, Minnesota, United States
• Study site — Missoula, Montana, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Bay Shore, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.